Chief at BARDA to Speak at 9th Anti-infectives Partnering Conference July 9-10, 2012 California
Joseph Larsen, Chief of Broad Spectrum Antimicrobials (BSA) Program and Division of CBRN Countermeasures at DHHS / ASPR / BARDA will give a featured presentation about Partnering and Working with BARDA at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA.
OrbiMed, 5AM Ventures, Frazier, and Aisling at 9th Anti-infectives Partnering Conference July 9 2012
OrbiMed Advisors, 5AM Ventures, Frazier Healthcare, and Aisling Capital will discuss “Investment Opportunities with Venture Capitalists” at the 9th Anti-Infectives Partnering and Deal-making Conference taking place on July 9-10, 2012 in San Francisco, CA.
Robert Webster to Keynote at Influenza Research & Development Meeting, July 9-10, San Francisco, CA
Robert Webster, Rose Marie Thomas Chair, Infectious Diseases, St. Jude’s Children’s Hospital will be giving a keynote presentation entitled “H5N1 Influenza-Has the Threat Been Overblown?” at the Influenza Research and Development Conference on July 9th-10th, 2012 in San Francisco, CA by GTC.
Thomas Reynolds, CMO of Seattle Genetics to Speak at Antibody Conference June 7-8, 2012 in San Diego, CA
Thomas Reynolds, Chief Medical Officer at Seattle Genetics will give a featured presentation on “Empowering Antibodies Through Drug Conjugation – the Brentuximab Vedotin Story” at GTC’s Antibody Design and Discovery Conference (June 7-8, 2012 in San Diego, CA)
Marvin A. Konstam, MD, FACC at the Cardiac Centers of Excellence Conference
“Transforming to an Enterprise of Cardiovascular Care through Provider System – Physician Alignment” will be presented by Marvin A. Konstam, MD, FACC at the Cardiac Centers of Excellence Conference.
Edmond Yunis to Speak at Antibody Conference June 7-8, 2012 in San Diego, CA
Edmond Yunis, Professor of Pathology at Harvard Medical School and Chief of Immunogenetics at the Dana-Farber Cancer Institute will give a featured presentation on “Humoral Mechanisms and Molecular Signatures of Latent Tuberculosis Infection” at GTC’s Antibody Design and Discovery Conference (June 7-8, 2012 in San Diego, CA)
Berthold Huppertz, Director of Biobank Graz to Speak at Biorepositories Conference June 7-8, 2012, San Diego, CA
Berthold Huppertz, Professor of Cell Biology at Medical University of Graz and Director and CEO at Biobank Graz will give a presentation on “Biobank Graz: Increasing Sample Quality via Automation from Collection to Storage” at GTC’s Biospecimens and Biorepositories Conference (June 7-8, 2012 in San Diego, CA)
Rade Drmanac, CSO, Complete Genomics Featured at GTC’s 2nd NGS Conference, May 29-31, Boston
Rade Drmanac, Chief Scientific Officer of Complete Genomics will be giving a featured presentation entitled “Large-scale Accurate Whole Genome Sequencing to Enable Genomic Medicine” at the 2nd Next Generation Sequencing Conference on May 29-31st in Boston, MA.
Announcing GTC’s Life Science Legal & Business Strategy Conference, June 7-8, 2012, in San Diego, CA
GTC’s Life Science Legal & Business Strategy Conference is the only biotech regulatory conference on the west coast. Providing executive level insight into the legal issues of greatest concern in today’s business environment, the conference also offers in depth knowledge and perspectives into the latest regulatory changes and how to develop plans to protect your organization and its products as well as prepare for opportunities that may only exist for a limited time.
Barry Morgan, GSK to Speak at 6th Drug Design & Medicinal Chem. Conf. (June 7-8, 2012, San Diego)
Barry A. Morgan, Vice President of Molecular Discovery Research, Site Head in Boston at GlaxoSmithKline to give a Keynote Presentation on “DNA Encoded Libraries: A Disruptive Technology for Lead Discovery” at the 6th Drug Design & Medicinal Chemistry Conference (June 7-8, 2012 in San Diego, CA)